Foley Senior Counsel R. Brian McCaslin authored an article titled “Are Patent Offices Ready for Personalized Medicine?” in the March/April 2009 issue of Bio-IT World. McCaslin discusses the unique challenges to the patent system presented by new sciences such as personalized medicine, stating that innovators seeking to patent new sciences should consider adapting their prosecution strategy to the current administrative landscape. He adds that innovators should consider postponing the filing date of an application until more information about the new science can be obtained.
Related Insights
30 August 2024
Viewpoints
FTC’s Ban on Noncompete Agreements Is Blocked
04 September 2024
Events
Navigating Intellectual Property While Building with AI
Foley Partner Eric Sophir will present on the topic of “Navigating Intellectual Property while building with AI” at the Martin Luther King Jr. Memorial Library on Wednesday, September 4, 2024, from 4:00 p.m.-5:00 p.m. EDT.
29 August 2024
Manufacturing Industry Advisor
2024 CPSC and FDA Enforcement Trends
The enforcement trends of 2023 have continued into 2024, especially with respect to the U.S. Consumer Product Safety Commission and the U.S. Food and Drug Administration.